Financhill
Back

Regulus Therapeutics Vs. Theriva Biologics Industry Stock Comparison

Sell
26

RGLS
Regulus Therapeutics

Last Price:
1.58
Seasonality Move:
15.35%
Sell
19

TOVX
Theriva Biologics

Last Price:
1.67
Seasonality Move:
22.01%
Sell
26
Regulus Therapeutics (RGLS) is a Sell

Is Regulus Therapeutics a Buy, Sell or Hold?

  • The current Regulus Therapeutics [RGLS] share price is $1.58. The Score for RGLS is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • RGLS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy, Sell or Hold?

  • The current Theriva Biologics [TOVX] share price is $1.68. The Score for TOVX is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • TOVX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RGLS Stock Price Chart

What is Regulus Therapeutics's stock price today?

  • The Regulus Therapeutics share price today is $1.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RGLS is experiencing selling pressure, which indicates risk of future bearish movement.

TOVX Stock Price Chart

What is Theriva Biologics's stock price today?

  • The Theriva Biologics share price today is $1.68
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TOVX is experiencing slight buying pressure.

RGLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 47.3 Sell
Chaikin Money Flow: -216681 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.53 - 1.67) Sell
Bollinger Bands (100): (1.53 - 2.11) Sell

TOVX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.77 Sell
Relative Strength Index (14 RSI): 34.76 Sell
Chaikin Money Flow: 518070 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.01 - 4.37) Sell
Bollinger Bands (100): (3.53 - 7.35) Sell

RGLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.6 Sell
20-day SMA: 1.6 Sell
50-day SMA: 1.62 Sell
200-day SMA: 1.84 Sell
8-day EMA: 1.61 Sell
20-day EMA: 1.61 Sell
50-day EMA: 1.66 Sell
200-day EMA: 1.78 Sell

TOVX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.66 Buy
20-day SMA: 2.95 Sell
50-day SMA: 4.01 Sell
200-day SMA: 8.39 Sell
8-day EMA: 1.87 Sell
20-day EMA: 2.65 Sell
50-day EMA: 3.87 Sell
200-day EMA: 8.02 Sell

Regulus Therapeutics Earnings Growth & RGLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.84 per share, and a decrease next year of $0.19 per share.

Theriva Biologics Earnings Growth & TOVX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.

Regulus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theriva Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):